JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.C500097200 on June 16, 2005

J. Biol. Chem., Vol. 280, Issue 31, 28761-28765, August 5, 2005
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/31/28761    most recent
C500097200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fingerman, I. M.
Right arrow Articles by Briggs, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fingerman, I. M.
Right arrow Articles by Briggs, S. D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Global Loss of Set1-mediated H3 Lys4 Trimethylation Is Associated with Silencing Defects in Saccharomyces cerevisiae*

Ian M. Fingerman{ddagger}§, Chia-Ling Wu{ddagger}§, Bradley D. Wilson{ddagger}§, and Scott D. Briggs{ddagger}§

From the {ddagger}Department of Biochemistry and the Cancer Center, Purdue University, West Lafayette, Indiana 47907 and the §Walther Cancer Institute, Indianapolis, Indiana 46202

Received for publication, March 7, 2005 , and in revised form, June 13, 2005.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
Post-translational histone modifications, such as acetylation, phosphorylation, ubiquitination, and methylation, have been correlated with regulation of gene expression. In Saccharomyces cerevisiae, Set1 has been identified as the sole histone methyltransferase required for histone H3 lysine 4 (Lys4) methylation. Yeast cells that do not express Set1 have several apparent phenotypes, including slow growth and defects in telomere, HML, and rDNA silencing. However, the mechanism by which the Set1 methyltransferase mediates differential histone H3 methylation (mono-, di-, and tri-) is still not understood, and the involvement of domains or regions in Set1 contributing to H3 Lys4 methylation has not been well characterized. In this study, the N terminus of Set1 was shown to be important for global and gene specific histone H3 trimethylation. We show that Set1 trimethyl-defective mutants can rescue a set1{Delta} slow growth defect. In contrast, Set1 trimethyl mutants were defective in telomere, rDNA, HML, and HMR silencing. Taken together, these data suggest that histone H3 Lys4 trimethylation is required for proper silencing, while mono- and/or dimethylation is sufficient for cell growth.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
The existence of histone methylation has been known for over 30 years (1) and recently site specific histone methylation and the corresponding methyltransferases have been identified (2, 3). The catalytic core for most histone lysine methyltransferases resides in the SET domain (2, 4). The SET domain is an evolutionarily conserved motif, with homologues present in organisms ranging from yeast to humans (5). In Saccharomyces cerevisiae, Set1 is the sole methyltransferase responsible for histone H3 lysine 4 (H3 Lys4) methylation and catalyzes the addition of up to three methyl groups to its substrate resulting in mono-, di-, or trimethylated lysine 4 (6-10). Cells that do not express Set1 have several apparent phenotypes, including slow growth and defects in telomere, HML, and rDNA silencing (6, 10-13).

Purification of Set1 indicates that Set1 is in a high molecular weight complex with seven other proteins (Swd1, Swd2, Swd3, Bre2, Sdc1, Spp1, and Shg1) and together with Set1 is referred to as COMPASS or SET1C (8, 9, 14). Several of the Set1-associated proteins are also critical for Set1-mediated histone H3 Lys4 methylation suggesting that their interactions with Set1 regulate enzymatic activity or targeting of Set1 to chromatin (8-10). More recently, human homologues of Set1 (MLL1, MLL2, and KIAA0339) have also been purified as protein complexes and have been shown to have histone H3 Lys4 methyltransferase activity (15-18). Furthermore, several of their complex members have been identified as the human homologues of the proteins associated with Set1 (14, 16, 17).

In budding yeast, H3 Lys4 trimethylation and Set1 are highly concentrated at chromatin near the 5' ends of open reading frames and is associated with transcriptionally active chromatin (7, 19, 20). In contrast, H3 Lys4 dimethylation can be located at intergenic regions, promoters, and open reading frames (13, 19, 21). Therefore, it is thought that H3 Lys4 dimethylation is more global and is located at regions of chromatin that are transcriptionally active, competent for transcription, or transcriptionally repressed (7, 13, 19-21). These results indicate that the different forms of H3 Lys4 methylation may have distinct and/or overlapping biological roles. However, the mechanism by which Set1 methyltransferase differentially methylates H3 (mono-, di-, and tri-) is still not understood, and potential domains within Set1 that regulate H3 Lys4 methylation have not been well characterized.

Set1 and COMPASS subunits have also been found to interact with the CTD of RNA polymerase II when it is phosphorylated at serine 5, and this interaction is dependent on the Paf1 elongation complex (19, 21). In addition, yeast deletion strains of Paf1 complex members lack both H3 Lys4 and Lys79 methylation (19, 21, 22). Based on these observations and chromatin localization studies of Set1 and Lys4 methylation, it has been proposed that H3 Lys4 methylation may play a role in transcription activation and/or elongation (19, 21). However, the exact mechanism by which Set1 and H3 Lys4 methylation functions in these processes is still poorly understood.

In this study, we generated N-terminal Set1 deletion mutants that lack global and gene specific H3 Lys4 trimethylation while maintaining normal levels of mono- and dimethylated H3 Lys4. We determined that the putative RNA recognition motif (RRM) domain in the N terminus of Set1 is needed for histone H3 Lys4 trimethylation. Using Set1 trimethyl-defective mutants, we showed that histone H3 Lys4 trimethylation alone is required for proper silencing of telomeres, rDNA, HML, and HMR loci, while only mono- and dimethylation were sufficient for proper cell growth suggesting that the different forms of histone H3 Lys4 methylation are playing distinct biological roles.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS AND DISCUSSION
 REFERENCES
 
Yeast Plasmids and Strains—Construction of the plasmid expressing FLAG-tagged full-length Set1 (1-1080) and Set1 (780-1080) has been described previously (6). The N-terminal truncation of Set1 (829-1080) was made by PCR amplification of the desired region of Set1 using the full-length SET1 plasmid as template. All constructs were engineered with a single FLAG epitope at the N terminus and subcloned into a yeast expression plasmid under the control of the ADH1 promoter and containing a URA3 or TRP1 selectable marker. The RRM deletion mutant (1-1080 {Delta}RRM) was made via site-directed deletion using the Stratagene Quikchange site-directed mutagenesis kit. Briefly, complementary oligonucleotides were designed that had homology both to the regions immediately upstream and downstream of the region to be deleted. PCR amplification of the template (Set1 1-1080) and subsequent steps were performed as described by the manufacturer. The following strains were used: MBY1198 (MAT{alpha} his3{Delta}200 ade2::hisG leu2{Delta}0 ura2{Delta}0 met15{Delta}0 trp1{Delta}63 Ty1his3AI-236r, Ty1ade2AI515), MBY1217 (MAT{alpha} his3{Delta}200 ade2::hisG leu2{Delta}0 ura2{Delta}0 met15{Delta}0 trp1{Delta}63 Ty1his3AI-236r, Ty1ade2AI515 set1{Delta}::TRP1) (6), MSY421 (MAT{alpha} ura3-52 leu2-3,112 trp1 his3 {Delta}[HHT1-HHF1] {Delta}[HHT2-HHF2] pMS329 copy I (URA3, HHT1-HHF-1) (23), MBY1587 (MAT{alpha} ura3-52 leu2-3,112 trp1 his3 {Delta}[HHT1-HHF1] {Delta}[HHT2-HHF2] pMS329 copy I (URA3, HHT1-HHF-1) set1{Delta}::KanMX4) (6), UCC506 (MATa ade2-101 his3-{Delta}200 leu2-{Delta}1 lys2-801 trp1-{Delta}1 ura3-52 URA::Tel-V-R) (24) UCC506 set1{Delta} (isogenic to UCC506, containing set1{Delta}::KanMX4; this study). UCC7262 (MATa ade2 his3 leu2 lys2 ura3 hhf1-hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR hmr::URA3,pMP9) (25), UCC7262 set1{Delta} (isogenic to UCC7262, containing set1{Delta}::KanMX4; this study). UCC7266 (MATa ade2 his3 leu2 lys2 ura3 hhf1-hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR hml::URA3,pMP9) (25), UCC7266 set1{Delta} (isogenic to UCC7262, containing set1{Delta}::KanMX4; this study). UCC1188 (MAT{alpha} leu2-{Delta}1 lys2-801 trp1 ura3 hhf1-hht1::LEU2 hhf2-hht2::HIS3 RDN1::URA3,pMP9) (25), UCC1188 set1{Delta} (isogenic to UCC1188, containing set1{Delta}::KanMX4; this study).

Preparation of Yeast Whole Cell Extracts and Immunoprecipitations—For analysis of yeast histones, yeast whole cell extracts were prepared as follows: 5-ml cultures of yeast were grown to mid-log phase (A600 = 1.0). Cells were harvested, washed with water and resuspended in 250 µl of 2 M NaOH with 8% {beta}-mercaptoethanol. Cells were incubated on ice for 5 min and then pelleted at 13,000 rpm for 2 min at 4 °C. Cell pellets were resuspended gently in 250 µl of Buffer A (40 mM HEPES-KOH, pH 7.5, 350 mM NaCl, 0.1% Tween 20, 10% glycerol, 1 µg/ml leupeptin, aprotinin, and pepstatin A, 1 mM phenylmethylsulfonyl fluoride) and pelleted as described above. Cell pellets were resuspended in 180 µl of 2x SDS-sample buffer. Five µl or 10 µl of each sample were loaded per lane for Western blotting. For immunoprecipitation of yeast Set1, 50-ml cultures of MBY1198 and MBY1217 expressing blank vector or the indicated FLAG-Set1 (1-1080) or FLAG-tagged Set1 mutants (1-1080 {Delta}RRM, 780-1080 and 829-1080) were grown to mid-log phase and harvested. Cells were washed with water, resuspended in Buffer A (see above) and lysed with glass beads using a mini-bead beater (Biospec Products). Lysates were clarified by centrifugation and removed to a new tube. M2 resin (Sigma) was added (10 µl) to each lysate and rotated at 4 °C for 2 h. M2 resin was pelleted by spinning at 3000 rpm in a microcentrifuge and washed two times for 5 min each with 1 ml of Buffer A. Immunoprecipitated Set1 was eluted from the M2-resin by the addition of 10 µl of 2x SDS-Laemmli sample buffer.

Electrophoresis and Western Blotting—Western blot analysis to detect methylated histones was performed as described previously (6). To detect FLAG-Set1, immunoprecipitates were resolved on 8% or 10% SDS-PAGE gels, transferred to PVDF1 membrane, and immunoblotted with monoclonal anti-FLAG antibody. Western blots directed against glyceraldehyde-3-phosphate dehydrogenase were also performed on the IP input to control for protein levels (data not shown).

Chromatin Immunoprecipitations—For analysis of PYK1, 100-ml cultures were grown as described (19). Briefly, cultures were grown in YP-ethanol (1% yeast extract, 2% peptone, 2% ethanol) to mid-log phase (A600 = 1.0) and split. Cells were washed and resuspended in either 50 ml of YP-ethanol or YPD (1% yeast extract, 2% peptone, 2% glucose) to induce expression of PYK1. Cells were induced for 1.5 h, harvested, and cross-linked with 1% formaldehyde. For analysis of GAL10, cultures were grown as described previously (26). Briefly, 100-ml cultures were grown in SC media (0.67% (w/v) yeast nitrogen base supplemented with amino acids, 2% glucose) lacking uracil overnight and split. Cells were harvested and resuspended in either SC-Ura or SC-Ura containing 0.5% glucose and 2% galactose. Cells were induced for 4 h, harvested, and cross-linked with 1% formaldehyde.

Chromatin immunoprecipitations were performed as described previously using H3 Lys4 dimethyl- and H3 Lys4 trimethyl-specific antibodies (Upstate%20Biotechnology">Upstate Biotechnology) (27). Immunoprecipitated DNA was analyzed by PCR using primers that have been described previously to analyze the promoter, 5' and 3' regions of PYK1 and GAL10 (19). Two additional oligonucleotides were designed to analyze a region of the GAL10 promoter (-290 to -40 bp). Their sequences are as follows: 5'-CACGGAGGAGAGTCTTCCGTCGGAG-3' and 5'-GGACGCAAAGAAGTTTAATAATCAT-3'.

Growth and Silencing Assay—Growth assays were performed as follows. Yeast strains MSY421 and MBY1587 were transformed with plasmids to express wild type, epitope-tagged, FLAG-Set1 (1-1080), FLAG-Set1 {Delta}RRM (1-1080 {Delta}RRM), FLAG-Set1 (780-1080), FLAG-Set1 (829-1080), or blank vector. Cells were grown to mid-log phase (A600 = 1.0), serially diluted 5-fold, and plated on SC-Trp plates. Cells were photographed after 36 h at 30 °C. Telomere silencing assays were performed as described previously (11). Briefly, strains UCC506 (MATa ade2-101 his3-{Delta}200 leu2-{Delta}1 lys2-801 trp1-{Delta}1 ura3-52 URA::Tel-V-R) and UCC506 set1{Delta} were transformed with the above plasmids. Individual isolates were grown 3 days to saturation in SC-Trp, normalized for A600, serially diluted (2-fold), and spotted (5 µl/spot) on SC-Trp or SC-Trp plates containing 5-fluoroorotic acid (5-FOA) (100 µg/ml, Bio 101, Inc.). Cell growth was monitored over time at 30 °C. Cells on SC-Trp plates were photographed after 24 h, and cells on SC-Trp + 5-FOA were photographed after 60 h. rDNA, HML, and HMR silencing were performed as described previously (13, 25). For rDNA silencing cells were grown 5 days to saturation, normalized for A600, serially diluted (4-fold), and spotted on SC-Trp or SC-Trp plates containing 5-FOA (100 µg/ml, Bio 101, Inc.). For HML and HMR silencing cells were grown overnight, diluted (5-fold), and spotted as described above. Cells on SC-Trp plates were photographed after 24 h. 5-FOA plates were photographed at 48 h.


   RESULTS AND DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
REFERENCES
 
To investigate the importance of the N terminus of Set1 in regulating H3 Lys4 methylation, two FLAG-tagged N-terminal set1 deletion constructs (780-1080 and 829-1080) were generated (Fig. 1A) and expressed in a yeast strain in which the endogenous SET1 was deleted (set1{Delta}). To determine the histone H3 Lys4 methylation status in these cells, yeast set1{Delta} strains containing blank plasmid (Vector) and the two N-terminal set1 deletion constructs (780-1080 and 829-1080) were grown to an A600 = 1.0 and extracted with 2x SDS-Laemmli sample buffer. Clarified supernatants were run on SDS-polyacrylamide gels, transferred to a PVDF membrane, and probed with methyl-specific antibodies (Upstate%20Biotechnology">Upstate Biotechnology) to mono-, di-, and trimethylated forms of histone H3 Lys4. As shown in Fig. 1B, H3Lys4 trimethylation was nearly abolished in set1{Delta} strains expressing N-terminal set1 deletion constructs (780-1080 and 829-1080). Trace amounts of H3 Lys4 trimethylation were detected after longer exposure time to film (Fig. 1B). Surprisingly, H3 Lys4 mono- and dimethylation were restored to similar levels to that of a wild-type isogenic strain, indicating that the N terminus of Set1 is specifically required for H3 Lys4 trimethylation. To confirm that the Set1 N-terminal deletion mutants (780-1080 and 829-1080) were expressed, mutant yeast strains were grown to an A600 = 1.0 and lysed using glass beads. Clarified supernatants were immunoprecipitated with an anti-FLAG affinity resin (M2 resin, Sigma). Immunoprecipitates were run on SDS-polyacrylamide gels, transferred to a PVDF membrane, and probed with anti-FLAG monoclonal antibodies (M2, Sigma). Western blots indicated equal expression of the two N-terminal set1 deletion constructs (780-1080 and 829-1080) (Fig. 1B). No FLAG-Set1 deletion mutants were detected in the unbound fraction (data not shown).

Besides the n-SET, SET, and post-SET domains of Set1, which are required for methyltransferase activity, the only other known domain found in Set1 is its putative RRM. The RRM is a domain commonly found in RNA-binding proteins and has been implicated in binding RNA, single-stranded DNA, as well as proteins (28). To test whether the putative RRM domain might be the region in the N terminus of Set1 that regulates H3 Lys4 trimethylation, we constructed a FLAG-tagged Set1 expression construct that lacked this domain (Fig. 1A). This deletion construct was expressed in the set1{Delta} strain and examined for H3 Lys4 methylation status. As shown in Fig. 1C, the Set1 {Delta}RRM (1-1080 {Delta}RRM) mutant restored H3 Lys4 mono- and dimethylation levels similar to wild-type cells and full-length Set1 (1-1080). Similar to the N-terminal Set1 deletion mutants (780-1080 and 829-1080), H3 Lys4 trimethylation was nearly abolished in the Set1 {Delta}RRM (1-1080 {Delta}RRM) mutant strain (Fig. 1C). Again, longer exposure time to film indicated the presence of trace amounts of H3 Lys4 trimethylation (Fig. 1C). Together these data suggest the RRM domain is at least one domain within the N terminus of Set1 that is needed for trimethylation. In further support of our data, Schlichter and Cairns (29) recently published a similar result showing that the RRM domain of Set1 is required for H3 Lys4 trimethylation. To determine the levels of protein expression, full-length FLAG-Set1 (1-1080) and FLAG-Set1 {Delta}RRM (1-1080 {Delta}RRM) were immunoprecipitated from whole cell extracts and immunoblotted with anti-FLAG antibodies (Fig. 1C). Our results showed expression of both full-length Set1 (1-1080) and Set1 {Delta}RRM (1-1080 {Delta}RRM). However, lower levels of Set1 {Delta}RRM (1-1080 {Delta}RRM) mutant protein were detected when compared with full-length Set1 (1-1080) (Fig. 1C). Again, no FLAG-Set1 (1-1080) or Set1 {Delta}RRM (1-1080 {Delta}RRM) was detected in the unbound fraction (data not shown). Together these data may indicate that the Set1 {Delta}RRM (1-1080 {Delta}RRM) mutant protein is less stable. Interestingly, Swd2, a Set1-associated protein, has been implicated in the protein stability of Set1 suggesting the possibility that Swd2 or other Set1-associated proteins (Swd1, Swd3, Spp1, Bre2, Sdc1, or Shg1) interact with the RRM domain to stabilize the protein levels of Set1 (30).



View larger version (41K):
[in this window]
[in a new window]
  		FIG. 1.
The N terminus of Set1 is required for global histone H3 Lys4 trimethylation. A, schematic representation of Set1 and Set1 deletion constructs used in this study. Amino acid positions of the RRM domain, n-SET, SET, and post-SET domains are indicated. All constructs are N-terminally tagged with a single FLAG epitope. B and C, Western blots using methyl-specific antibodies shows the methylation status of H3 Lys4 in yeast strains expressing full-length Set1 (1-1080) and Set1 mutants (1-1080 {Delta}RRM, 780-1080, and 829-1080). Long exposure (Long Exp.) represents the same trimethyl immunoblot (above) but 15x longer exposure to film. Antibodies directed against general histone H3 (Abcam) were used as a loading control. Anti-FLAG immunoblots were performed to examine the protein levels of the Set1 mutants.

 
To examine the effects Set1 trimethyl-deficient mutants at the gene level, chromatin immunoprecipitations were preformed using H3 Lys4 di- and trimethyl-specific antibodies. The GAL10 and PYK1 loci, which are known targets of Set1 and H3 Lys4 methylation, were examined (19, 31, 32). A complete loss of H3 Lys4 trimethylation was observed at these loci in our set1{Delta} strain expressing Set1 829-1080 under conditions in which GAL10 and PYK1 were either induced (Fig. 2) or uninduced (data not shown). Importantly, the level of H3 Lys4 dimethylation was similar to that of wild type cells (Fig. 2). Together these data suggest that our Set1 trimethyl-deficient mutants are still targeted to chromatin and are competent to dimethylate chromatin templates.

With the establishment of Set1 mutants that are defective for H3 Lys4 trimethylation but not mono- or dimethylation, we wanted to determine whether differential methylation of H3 Lys4 played a distinct biological function. Deletion of SET1 in S. cerevisiae leads to the loss of telomere, HML, and rDNA silencing (6, 8, 10-13). In addition, some yeast strains deleted for SET1 also demonstrate a slow growth phenotype (6). To examine the extent of H3 Lys4 methylation (mono-, di-, or trimethylation) associated with these known set1{Delta} phenotypes, we expressed full-length Set1 (1-1080), Set1 {Delta}RRM (1-1080 {Delta}RRM), and both N-terminal Set1 deletions (780-1080 and 829-1080) in set1{Delta} strains that either have growth or silencing defects (6, 8, 10, 11).

To determine whether slow growth is the result of a loss in H3 Lys4 mono-, di-, or trimethylation, the yeast strain background, MSY421, was used. This strain was previously shown to have a significant growth defect when SET1 was deleted (6). Both full-length Set1 (1-1080), Set1 {Delta}RRM (1-1080 {Delta}RRM), and the two N-terminal Set1 deletion mutants (780-1080 and 829-1080) were expressed in the MSY421 set1{Delta} strain. All cells were grown to A600 = 1.0, and 5-fold serial dilutions were spotted on plates containing synthetic complete media lacking uracil (SC-Ura, Bio 101, Inc.) and incubated at 30 °C. Interestingly, set1{Delta} strains expressing Set1 trimethylation mutants (1-1080 {Delta}RRM, 780-1080, and 829-1080) rescued the slow growth phenotype similar to that of full-length Set1 (Fig. 3). Furthermore, these data would suggest that mono- or dimethylation of H3 Lys4 or a combination of both is sufficient for proper cell growth.

To determine whether the observed loss of telomere silencing in a set1{Delta} strain is the result of losing H3 Lys4 mono-, di-, or trimethylation, SET1 was deleted in a strain where a URA3 gene has been integrated at a subtelomere locus (24). Surprisingly, we observed that the set1{Delta} cells expressing Set1 {Delta}RRM (1-1080 {Delta}RRM) or N-terminal Set1 deletions (780-1080 and 829-1080) showed a dramatic sensitivity to 5-FOA (Bio 101, Inc.) as compared with both wild-type cells transformed with blank plasmid (Vector) or set1{Delta} cells expressing full-length Set1 (1-1080) (Fig. 4). Interestingly, cells expressing Set1 trimethylation mutants (1-1080 {Delta}RRM, 780-1080, and 829-1080) will eventually grow on 5-FOA plates, albeit in a diminished capacity, upon longer incubation periods at 30 °C (data not shown). This is consistent with our data indicating trace amount of H3 Lys4 trimethylation in cells expressing trimethyl-defective mutants (Fig. 1, B and C). Since these cells contain proper H3 Lys4 mono- and dimethylation, our data suggest that H3 Lys4 trimethylation is needed for proper telomere silencing.



View larger version (41K):
[in this window]
[in a new window]
  		FIG. 2.
Set1 trimethyl-defective mutants show gene-specific loss of H3 Lys4 trimethylation but not H3 Lys4 dimethylation. Chromatin immunoprecipitations were performed at GAL10 and PYK1 using antibodies specific to di- or trimethylated Lys4. A and B, chromatin immunoprecipitation eluates were examined by PCR at the indicated regions (A-C) and analyzed by agarose gel electrophoresis. Chromatin immunoprecipitation data shown represent both PYK1 and GAL10 under induced conditions.

 
To determine whether silencing at rDNA, HML, and HMR loci is dependent upon H3 Lys4 trimethylation, similar assays, as described above, were performed in strains lacking Set1 and containing a URA3 gene integrated at the rDNA locus and the HMR and HML silent mating type loci (24, 25). In all instances, cells that expressed Set1 mutants that are deficient for H3 Lys4 trimethylation exhibit sensitivity to 5-FOA as compared with both wild-type cells transformed with blank plasmid (Vector) or set1{Delta} cells expressing full-length Set1 (1-1080) (Fig. 4). This data again suggests that H3 Lys4 trimethylation is also needed for proper silencing at the rDNA, HML, and HMR loci.

Interestingly, at the different silent loci, silencing seems to be compromised at varying degrees when SET1 is deleted or when expressing the Set1 trimethyl-deficient mutants in a set1{Delta}. Although the reason for this difference is not known, this has been commonly observed among other protein factors that disrupt silencing. However, various explanations could account for our observed differences. For example, the differences between HML and HMR silencing could be a consequence on how the URA3 gene was previously integrated in these strains. It has been shown previously that the URA3 gene is silenced better at the HML than HMR locus due to the way the gene was inserted (33). Therefore, HMR silencing in this strain has been shown to be more sensitive to silencing defects than HML (33). Another strain difference is that HMR, HML, and rDNA strains contain one gene copy of histones H3 and H4, therefore histone amounts may also contribute to these silencing differences. Although we speculate that some of these differences are due to subtle strain differences, it is also possible these differences are due to the type or amount of protein factors (e.g. Sir proteins) that are required for silencing at each of these distinct loci (34).

Our results demonstrate a strong correlation between H3 Lys4 trimethylation and silencing. Although, the mechanism by which H3 Lys4 trimethylation regulates silencing is still unclear, it has been proposed that loss of histone methylation at H3 Lys4 and/or H3 Lys79 methylation allows promiscuous binding of Sir proteins to euchromatic regions, which results in titrating away Sir proteins from silent loci (35). In support of this model, it has recently been shown that Sir3 localization is disrupted in a yeast strain expressing a catalytically inactive mutant of Set1 and that Sir3 can bind to unmodified histone peptides but not peptides trimethylated at H3 Lys4 (12). It will now be interesting to determine whether similar results are observed using yeast strains lacking only H3 Lys4 trimethylation. However, other possibilities could still exist. For example, protein-protein interactions at the N terminus of Set1 may be needed for proper gene silencing, or Set1-mediated trimethylation may regulate expression of a known or unknown silencing factor(s).



View larger version (41K):
[in this window]
[in a new window]
  		FIG. 3.
The N terminus of Set1 is not essential for cell growth. Yeast strains MSY421 and MBY1587 were transformed with the indicated plasmids to determine whether H3 Lys4 trimethylation is essential for growth. Cells were grown to mid-log phase (A600 = 1.0), serially diluted 5-fold, and plated on SC-Trp plates. Cells were photographed after 36 h of incubation at 30 °C.

 
It has been indicated by several groups that H3 Lys4 trimethylation plays a role in transcriptional activation and/or elongation (7, 19-21, 36). To determine the role of Set1 trimethyl-deficient mutants in transcription, mRNA levels of known Set1 target genes GAL1, GAL10, and PYK1 (19, 31, 32, 37) were examined under uninduced and induced conditions. Surprisingly, reverse transcription-PCR and quantitative real time PCR analysis revealed no significant changes in GAL1, GAL10, and PYK1 steady state mRNA levels under uninduced or induced conditions in either set1{Delta} cells or set1{Delta} cells expressing Set1 trimethyl-deficient mutants (data not shown). These data suggest that specific loss of H3 Lys4 trimethylation is not sufficient to disrupt transcription of these Set1 targeted genes. In addition, set1{Delta} and Set1 trimethyl-deficient mutant strains do not show a hypersensitive phenotype when plated on media containing 6-azauracil, suggesting they are not defective in transcriptional elongation.2 Further investigation will be needed to assess the precise role of Set1-mediated Lys4 trimethylation in transcriptional activation and elongation.

In summary, this study demonstrates that a region outside the SET domain (i.e. the RRM domain or other domains in the N terminus of Set1) is required for regulation of Set1-mediated trimethylation. This is in contrast to Set7/9 and Dim5 histone methyltransferases in which a conserved tyrosine or phenylalanine residue within the SET domain mediates the degree of histone methylation (38, 39). In addition, Set1 trimethyl-specific mutants have allowed us to discover that differential H3 Lys4 methylation is required for distinct biological functions such as proper cell growth and telomere, rDNA, HML, and HMR silencing. Surprisingly, we were unable to determine a role for H3 Lys4 trimethylation in transcription. Further investigation will be needed to determine precise mechanism of how Set1-mediated Lys4 mono-, di-, and trimethylation can regulate these biological processes. Since Set1 exists in a high molecular weight complex, it is likely that Set1-associated factors will play a significant role in mediating the distinct forms of H3 Lys4 methylation (8, 9, 14). These and other Set1 methyl-specific mutants will be useful in dissecting out the biological mechanism of how the different methylation states in the eukaryotic genome effects chromatin structure and function.



View larger version (80K):
[in this window]
[in a new window]
  		FIG. 4.
The N terminus of Set1 is required for silencing. Strains UCC506 and UCC506 set1{Delta}(TEL-V), UCC7262 and UCC7262 set1{Delta}(HMR), UCC7266 and UCC7266 set1{Delta}(HML), and UCC1188 and UCC1188 set1{Delta}(rDNA) were transformed with the indicated plasmids. For silencing assays, individual isolates were grown to saturation, normalized for A600, and serially diluted and spotted on SC-Trp or SC-Trp/5-FOA plates. Cell growth was monitored at 30 °C. Cells on SC-Trp plates were photographed after 24 h, and cells on SC-Trp + 5-FOA were photographed after 48 h (HMR, HML, rDNA) or after 60 h (TEL).

 

   FOOTNOTES
 
* This work was supported by the Walther Cancer Institute, Purdue Cancer Center, American Cancer Society Institutional Grant, Indiana Elks Charities, Inc., and the Purdue Department of Biochemistry. This is journal paper number 17682 from the Purdue University Agricultural Experiment Station. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

A Sidney Kimmel Scholar. To whom correspondence should be addressed: Dept. of Biochemistry, Purdue University, 175 S. University, West Lafayette, IN 47907. Tel.: 765-494-0112; Fax: 765-494-7897; E-mail: sdbriggs{at}purdue.edu.

1 The abbreviations used are: PVDF, polyvinylidene fluoride; 5-FOA, 5-fluoroorotic acid; RRM, RNA recognition motif. Back

2 I. M. Fingerman and S. D. Briggs, unpublished observation. Back


   ACKNOWLEDGMENTS
 
We thank Ann Kirchmaier, Joe Ogas, and Harry Charbonneau for helpful discussions; Dan Gottschling for the UCC506, UCC7266, UCC7262, and UCC1188 yeast silencing strains; Mary Bryk for the MBY1198, 1217 and 1587 yeast strains; and Peter Cheung and Doug Mersman for critical review of the manuscript.



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 

  1. Murray, K. (1964) Biochemistry 127, 10-15
  2. Lachner, M., O'Sullivan, R. J., and Jenuwein, T. (2003) J. Cell Sci. 116, 2117-2124[Free Full Text]
  3. Peterson, C. L., and Laniel, M. A. (2004) Curr. Biol. 14, R546-R551[CrossRef][Medline] [Order article via Infotrieve]
  4. Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z. W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., and Jenuwein, T. (2000) Nature 406, 593-599[CrossRef][Medline] [Order article via Infotrieve]
  5. Jenuwein, T., Laible, G., Dorn, R., and Reuter, G. (1998) Cell. Mol. Life Sci. 54, 80-93[CrossRef][Medline] [Order article via Infotrieve]
  6. Briggs, S. D., Bryk, M., Strahl, B. D., Cheung, W. L., Davie, J. K., Dent, S. Y. R., Winston, F., and Allis, C. D. (2001) Genes Dev. 15, 3286-3295[Abstract/Free Full Text]
  7. Santos-Rosa, H., Schneider, R., Bannister, A. J., Sherriff, J., Bernstein, B. E., Emre, N. C. T., Schreiber, S. L., Mellor, J., and Kouzarides, T. (2002) Nature 419, 407-411[CrossRef][Medline] [Order article via Infotrieve]
  8. Nagy, P. L., Griesenbeck, J., Kornberg, R. D., and Cleary, M. L. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 90-94[Abstract/Free Full Text]
  9. Roguev, A., Schaft, D., Shevchenko, A., Pijnappel, W. W. M. P., Wilm, M., Aasland, R., and Stewart, A. F. (2001) EMBO J. 20, 7137-7148[CrossRef][Medline] [Order article via Infotrieve]
  10. Krogan, N. J., Dover, J., Khorrami, S., Greenblatt, J. F., Schneider, J., Johnston, M., and Shilatifard, A. (2002) J. Biol. Chem. 277, 10753-10755[Abstract/Free Full Text]
  11. Nislow, C., Ray, E., and Pillus, L. (1997) Mol. Biol. Cell 8, 2421-2436[Abstract/Free Full Text]
  12. Santos-Rosa, H., Bannister, A. J., Dehe, P. M., Geli, V., and Kouzarides, T. (2004) J. Biol. Chem. 279, 47506-47512[Abstract/Free Full Text]
  13. Bryk, M., Briggs, S. D., Strahl, B. D., Curcio, M. J., Allis, C. D., and Winston, F. (2002) Curr. Biol. 12, 165-170[CrossRef][Medline] [Order article via Infotrieve]
  14. Miller, T., Krogan, N. J., Dover, J., Erdjument-Bromage, H., Tempst, P., Johnston, M., Greenblatt, J. F., and Shilatifard, A. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 12902-12907[Abstract/Free Full Text]
  15. Milne, T. A., Briggs, S. D., Brock, H. W., Martin, M. E., Gibbs, D., Allis, C. D., and Hess, J. L. (2002) Mol. Cell 10, 1107-1117[CrossRef][Medline] [Order article via Infotrieve]
  16. Yokoyama, A., Wang, Z., Wysocka, J., Sanyal, M., Aufiero, D. J., Kitabayashi, I., Herr, W., and Cleary, M. L. (2004) Mol. Cell. Biol. 24, 5639-5649[Abstract/Free Full Text]
  17. Wysocka, J., Myers, M. P., Laherty, C. D., Eisenman, R. N., and Herr, W. (2003) Genes Dev. 17, 896-911[Abstract/Free Full Text]
  18. Hughes, C. M., Rozenblatt-Rosen, O., Milne, T. A., Copeland, T. D., Levine, S. S., Lee, J. C., Hayes, D. N., Shanmugam, K. S., Bhattacharjee, A., Biondi, C. A., Kay, G. F., Hayward, N. K., Hess, J. L., and Meyerson, M. (2004) Mol. Cell 13, 587-597[CrossRef][Medline] [Order article via Infotrieve]
  19. Ng, H. H., Robert, F., Young, R. A., and Struhl, K. (2003) Mol. Cell 11, 709-719[CrossRef][Medline] [Order article via Infotrieve]
  20. Bernstein, B. E., Humphrey, E. L., Erlich, R. L., Schneider, R., Bouman, P., Liu, J. S., Kouzarides, T., and Schreiber, S. L. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 8695-8700[Abstract/Free Full Text]
  21. Krogan, N. J., Dover, J., Wood, A., Schneider, J., Heidt, J., Boateng, M. A., Dean, K., Ryan, O. W., Golshani, A., Johnston, M., Greenblatt, J. F., and Shilatifard, A. (2003) Mol. Cell 11, 721-729[CrossRef][Medline] [Order article via Infotrieve]
  22. Xiao, T., Kao, C. F., Krogan, N. J., Sun, Z. W., Greenblatt, J. F., Osley, M. A., and Strahl, B. D. (2005) Mol. Cell. Biol. 25, 637-651[Abstract/Free Full Text]
  23. Morgan, B. A., Mittman, B. A., and Smith, M. M. (1991) Mol. Cell. Biol. 11, 4111-4120[Abstract/Free Full Text]
  24. Gottschling, D. E., Aparicio, O. M., Billington, B. L., and Zakian, V. A. (1990) Cell 63, 751-762[CrossRef][Medline] [Order article via Infotrieve]
  25. van Leeuwen, F., Gafken, P. R., and Gottschling, D. E. (2002) Cell 109, 745-756[CrossRef][Medline] [Order article via Infotrieve]
  26. Carvin, C. D., and Kladde, M. P. (2004) J. Biol. Chem. 279, 33057-33062[Abstract/Free Full Text]
  27. Kuo, M. H., and Allis, C. D. (1999) Methods 19, 425-433[CrossRef][Medline] [Order article via Infotrieve]
  28. Stefl, R., Skrisovska, L., and Allain, F. H. (2005) EMBO Rep. 6, 33-38[CrossRef][Medline] [Order article via Infotrieve]
  29. Schlichter, A., and Cairns, B. R. (2005) EMBO J. 24, 1222-1231[CrossRef][Medline] [Order article via Infotrieve]
  30. Dichtl, B., Aasland, R., and Keller, W. (2004) RNA (N. Y.) 10, 965-977
  31. Ezhkova, E., and Tansey, W. P. (2004) Mol. Cell 13, 435-442[CrossRef][Medline] [Order article via Infotrieve]
  32. Daniel, J. A., Torok, M. S., Sun, Z. W., Schieltz, D., Allis, C. D., Yates, J. R., III, and Grant, P. A. (2004) J. Biol. Chem. 279, 1867-1871[Abstract/Free Full Text]
  33. Singer, M. S., Kahana, A., Wolf, A. J., Meisinger, L. L., Peterson, S. E., Goggin, C., Mahowald, M., and Gottschling, D. E. (1998) Genetics 150, 613-632[Abstract/Free Full Text]
  34. Rusche, L. N., Kirchmaier, A. L., and Rine, J. (2003) Annu. Rev. Biochem. 72, 481-516[CrossRef][Medline] [Order article via Infotrieve]
  35. van Leeuwen, F., and Gottschling, D. E. (2002) Curr. Opin. Cell. Biol. 14, 756-762[CrossRef][Medline] [Order article via Infotrieve]
  36. Hampsey, M., and Reinberg, D. (2003) Cell 113, 429-432[CrossRef][Medline] [Order article via Infotrieve]
  37. Henry, K. W., Wyce, A., Lo, W. S., Duggan, L. J., Emre, N. C., Kao, C. F., Pillus, L., Shilatifard, A., Osley, M. A., and Berger, S. L. (2003) Genes Dev. 17, 2648-2663[Abstract/Free Full Text]
  38. Zhang, X., Yang, Z., Khan, S. I., Horton, J. R., Tamaru, H., Selker, E. U., and Cheng, X. (2003) Mol. Cell 12, 177-185[CrossRef][Medline] [Order article via Infotrieve]
  39. Collins, R. E., Tachibana, M., Tamaru, H., Smith, K. M., Jia, D., Zhang, X., Selker, E. U., Shinkai, Y., and Cheng, X. (2005) J. Biol. Chem. 280, 5563-5570[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Mol. Cell. Biol.Home page
J.-H. Lee and D. G. Skalnik
Wdr82 Is a C-Terminal Domain-Binding Protein That Recruits the Setd1A Histone H3-Lys4 Methyltransferase Complex to Transcription Start Sites of Transcribed Human Genes
Mol. Cell. Biol., January 15, 2008; 28(2): 609 - 618.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
Y. Jin, A. M. Rodriguez, J. D. Stanton, A. A. Kitazono, and J. J. Wyrick
Simultaneous Mutation of Methylated Lysine Residues in Histone H3 Causes Enhanced Gene Silencing, Cell Cycle Defects, and Cell Lethality in Saccharomyces cerevisiae
Mol. Cell. Biol., October 1, 2007; 27(19): 6832 - 6841.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Jiang, J. N. Smith, S. L. Anderson, P. Ma, C. A. Mizzen, and N. L. Kelleher
Global Assessment of Combinatorial Post-translational Modification of Core Histones in Yeast Using Contemporary Mass Spectrometry: LYS4 TRIMETHYLATION CORRELATES WITH DEGREE OF ACETYLATION ON THE SAME H3 TAIL
J. Biol. Chem., September 21, 2007; 282(38): 27923 - 27934.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
I. M. Fingerman, H.-C. Li, and S. D. Briggs
A charge-based interaction between histone H4 and Dot1 is required for H3K79 methylation and telomere silencing: identification of a new trans-histone pathway
Genes & Dev., August 15, 2007; 21(16): 2018 - 2029.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Tu, E. M. M. Bulloch, L. Yang, C. Ren, W.-C. Huang, P.-H. Hsu, C.-H. Chen, C.-L. Liao, H.-M. Yu, W.-S. Lo, et al.
Identification of Histone Demethylases in Saccharomyces cerevisiae
J. Biol. Chem., May 11, 2007; 282(19): 14262 - 14271.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. N. Laribee, Y. Shibata, D. P. Mersman, S. R. Collins, P. Kemmeren, A. Roguev, J. S. Weissman, S. D. Briggs, N. J. Krogan, and B. D. Strahl
CCR4/NOT complex associates with the proteasome and regulates histone methylation
PNAS, April 3, 2007; 104(14): 5836 - 5841.
[Abstract] [Full Text] [PDF]

Home page
 Brief Funct Genomic ProteomicHome page
L. Gao and D. S. Gross
Using genomics and proteomics to investigate mechanisms of transcriptional silencing in Saccharomyces cerevisiae
Brief Funct Genomic Proteomic, December 1, 2006; 5(4): 280 - 288.
[Abstract] [Full Text] [PDF]

Home page
 Appl. Environ. Microbiol.Home page
J. Houghton-Larsen and A. Brandt
Fermentation of High Concentrations of Maltose by Saccharomyces cerevisiae Is Limited by the COMPASS Methylation Complex
Appl. Envir. Microbiol., November 1, 2006; 72(11): 7176 - 7182.
[Abstract] [Full Text] [PDF]

Home page
 Brief Funct Genomic ProteomicHome page
M. A. Osley
Regulation of histone H2A and H2B ubiquitylation
Brief Funct Genomic Proteomic, September 1, 2006; 5(3): 179 - 189.
[Abstract] [Full Text] [PDF]

Home page
 GeneticsHome page
J. E. Mueller, M. Canze, and M. Bryk
The Requirements for COMPASS and Paf1 in Transcriptional Silencing and Methylation of Histone H3 in Saccharomyces cerevisiae
Genetics, June 1, 2006; 173(2): 557 - 567.
[Abstract] [Full Text] [PDF]

Home page
 Plant CellHome page
K. van Dijk, K. E. Marley, B.-r. Jeong, J. Xu, J. Hesson, R. L. Cerny, J. H. Waterborg, and H. Cerutti
Monomethyl Histone H3 Lysine 4 as an Epigenetic Mark for Silenced Euchromatin in Chlamydomonas
PLANT CELL, September 1, 2005; 17(9): 2439 - 2453.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/31/28761    most recent
C500097200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fingerman, I. M.